{"DataElement":{"publicId":"6438205","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma AJCC Edition 8 Clinical Group Stage","preferredDefinition":"Clinical stage group based on the combination of T, N, and M categories and relevant prognostic factors for esophageal squamous cell carcinoma, using AJCC Ed. 8 criteria.","longName":"ESCC_AJC8_CLN_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6438184","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma Clinical Stage Grouping","preferredDefinition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6438168v1.0:2925061v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6438168","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma","preferredDefinition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor.","longName":"C4024","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Squamous Cell Carcinoma","conceptCode":"C4024","definition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A4045F-27AA-42A2-E053-F662850AA860","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2925061","version":"1","preferredName":"Clinical Stage Grouping","preferredDefinition":"Having to do with the examination and treatment of patients.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25398:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-281E-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"76A42B3D-040A-01D0-E053-F662850AEFF6","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"10-4-18 Changed from Draft New to Released/tmt. 9/24/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6438042","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma American Joint Committee on Cancer Edition 8 Clinical Group Stage","preferredDefinition":"A term that refers to the clinical staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6438042v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVB","valueDescription":"Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438044","version":"1","preferredName":"Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438044","preferredDefinition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133453","definition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1DCFF-4F89-528D-E053-F662850AA2C7","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A1DCFF-4FA2-528D-E053-F662850AA2C7","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438046","version":"1","preferredName":"Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438046","preferredDefinition":"Stage IVA includes: (T4, N0-2, M0); (Any T, N3, M0). T4: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133452","definition":"Stage IVA includes: (T4, N0-2, M0); (Any T, N3, M0). T4: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1DCFF-4FAF-528D-E053-F662850AA2C7","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A1DCFF-4FC8-528D-E053-F662850AA2C7","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"III","valueDescription":"Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438048","version":"1","preferredName":"Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438048","preferredDefinition":"Stage III includes: (T3, N1, M0); (T1-3, N2, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133450","definition":"Stage III includes: (T3, N1, M0); (T1-3, N2, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1DCFF-4FD5-528D-E053-F662850AA2C7","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A1DCFF-4FEE-528D-E053-F662850AA2C7","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"II","valueDescription":"Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438050","version":"1","preferredName":"Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438050","preferredDefinition":"Stage II includes: (T2, N0-1, M0); (T3, N0, M0). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133449","definition":"Stage II includes: (T2, N0-1, M0); (T3, N0, M0). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1DCFF-4FFB-528D-E053-F662850AA2C7","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A1DCFF-5014-528D-E053-F662850AA2C7","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"I","valueDescription":"Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438052","version":"1","preferredName":"Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438052","preferredDefinition":"Stage I includes: T1, N0-1, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133448","definition":"Stage I includes: T1, N0-1, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1DCFF-5021-528D-E053-F662850AA2C7","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A1DCFF-503A-528D-E053-F662850AA2C7","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"0","valueDescription":"Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438054","version":"1","preferredName":"Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438054","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133447","definition":"Stage 0 includes: Tis, N0, M0. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1DCFF-5047-528D-E053-F662850AA2C7","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A1DCFF-5060-528D-E053-F662850AA2C7","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6438041","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the clinical staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C133444:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage","conceptCode":"C133444","definition":"A term that refers to the clinical staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1DCFF-4F5C-528D-E053-F662850AA2C7","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"76A1DCFF-4F6D-528D-E053-F662850AA2C7","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"10-4-18 Changed from Draft New to Released/tmt. Content reviewed and approved by requesting organization. 9/24/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6437866","version":"1","longName":"Esophagus and Esophagogastric Junction","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical disease stage","type":"Preferred Question Text","description":"Clinical disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"76A310B9-9F3D-2C5C-E053-F662850A10ED","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"10-4-18 Changed from Draft New to Released/tmt. Content reviewed and approved by requesting organization. 9-24-18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}